@article{a596030a477546e7a1534bad689ec6fa,
title = "Cost effectiveness of entecavir versus lamivudine with adefovir salvage in HBeAg-positive chronic hepatitis B",
keywords = "Adefovir, therapeutic use, Cost utility, Entecavir, therapeutic use, Hepatitis B, treatment, Lamivudine, therapeutic use, Research and development",
author = "Veenstra, \{David L.\} and Sullivan, \{Sean D.\} and Lauren Clarke and Iloeje, \{Uche H.\} and Eskinder Tafesse and \{Di Bisceglie\}, Adrian and Kowdley, \{Kris V.\} and Gish, \{Robert G.\}",
year = "2007",
doi = "10.2165/00019053-200725110-00006",
language = "English",
volume = "25",
pages = "963--977",
journal = "PharmacoEconomics",
issn = "1170-7690",
number = "11",
}